Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2125653714', 'doi': 'https://doi.org/10.1111/dom.12093', 'title': 'Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus', 'display_name': 'Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus', 'publication_year': 2013, 'publication_date': '2013-04-04', 'ids': {'openalex': 'https://openalex.org/W2125653714', 'doi': 'https://doi.org/10.1111/dom.12093', 'mag': '2125653714', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23489301'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/dom.12093', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S148394532', 'display_name': 'Diabetes Obesity and Metabolism', 'issn_l': '1462-8902', 'issn': ['1462-8902', '1463-1326'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056816871', 'display_name': 'William B. White', 'orcid': 'https://orcid.org/0000-0001-8936-967X'}, 'institutions': [{'id': 'https://openalex.org/I140172145', 'display_name': 'University of Connecticut', 'ror': 'https://ror.org/02der9h97', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I140172145']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'W. B. White', 'raw_affiliation_strings': ['Calhoun Cardiology Center; University of Connecticut School of Medicine; Farmington CT USA'], 'affiliations': [{'raw_affiliation_string': 'Calhoun Cardiology Center; University of Connecticut School of Medicine; Farmington CT USA', 'institution_ids': ['https://openalex.org/I140172145']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059098934', 'display_name': 'Richard E. Pratley', 'orcid': 'https://orcid.org/0000-0002-2912-1389'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. Pratley', 'raw_affiliation_strings': ['Florida Hospital Diabetes Institute Orlando FL USA'], 'affiliations': [{'raw_affiliation_string': 'Florida Hospital Diabetes Institute Orlando FL USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011829580', 'display_name': 'Penny Fleck', 'orcid': 'https://orcid.org/0000-0003-3597-975X'}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210106190', 'display_name': 'Deerfield (United States)', 'ror': 'https://ror.org/02bph6v17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210106190']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'P. Fleck', 'raw_affiliation_strings': ['Takeda Global Research & Development Inc., Deerfield, IL, USA'], 'affiliations': [{'raw_affiliation_string': 'Takeda Global Research & Development Inc., Deerfield, IL, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210106190']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050991242', 'display_name': 'Melvin Munsaka', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210106190', 'display_name': 'Deerfield (United States)', 'ror': 'https://ror.org/02bph6v17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210106190']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M. Munsaka', 'raw_affiliation_strings': ['Takeda Global Research & Development Inc., Deerfield, IL, USA'], 'affiliations': [{'raw_affiliation_string': 'Takeda Global Research & Development Inc., Deerfield, IL, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210106190']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024080015', 'display_name': 'Michie Hisada', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210106190', 'display_name': 'Deerfield (United States)', 'ror': 'https://ror.org/02bph6v17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210106190']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M. Hisada', 'raw_affiliation_strings': ['Takeda Global Research & Development Inc., Deerfield, IL, USA'], 'affiliations': [{'raw_affiliation_string': 'Takeda Global Research & Development Inc., Deerfield, IL, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210106190']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017078461', 'display_name': 'Candy Wilson', 'orcid': 'https://orcid.org/0000-0001-5913-1521'}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210106190', 'display_name': 'Deerfield (United States)', 'ror': 'https://ror.org/02bph6v17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210106190']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'C. Wilson', 'raw_affiliation_strings': ['Takeda Global Research & Development Inc., Deerfield, IL, USA'], 'affiliations': [{'raw_affiliation_string': 'Takeda Global Research & Development Inc., Deerfield, IL, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210106190']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5062737940', 'display_name': 'Venu Menon', 'orcid': 'https://orcid.org/0000-0003-4410-2677'}, 'institutions': [{'id': 'https://openalex.org/I1316902750', 'display_name': 'Cleveland Clinic', 'ror': 'https://ror.org/03xjacd83', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1316902750']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'V. Menon', 'raw_affiliation_strings': ['Department of Cardiovascular Medicine; Cleveland Clinic; Cleveland; OH; USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Cardiovascular Medicine; Cleveland Clinic; Cleveland; OH; USA', 'institution_ids': ['https://openalex.org/I1316902750']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4940, 'currency': 'USD', 'value_usd': 4940, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 15.644, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 118, 'citation_normalized_percentile': {'value': 0.938564, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '15', 'issue': '7', 'first_page': '668', 'last_page': '673'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Role of Fibroblast Activation in Cancer Progression', 'score': 0.9783, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10754', 'display_name': 'Epidemiology and Management of Neuroendocrine Tumors', 'score': 0.95, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/alogliptin', 'display_name': 'Alogliptin', 'score': 0.9930377}, {'id': 'https://openalex.org/keywords/mace', 'display_name': 'Mace', 'score': 0.64241886}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitors', 'display_name': 'Dipeptidyl Peptidase-4 Inhibitors', 'score': 0.528728}, {'id': 'https://openalex.org/keywords/type-2-diabetes', 'display_name': 'Type 2 Diabetes', 'score': 0.523094}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.47953796}, {'id': 'https://openalex.org/keywords/stroke', 'display_name': 'Stroke (engine)', 'score': 0.42748144}], 'concepts': [{'id': 'https://openalex.org/C2780012697', 'wikidata': 'https://www.wikidata.org/wiki/Q4734170', 'display_name': 'Alogliptin', 'level': 5, 'score': 0.9930377}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8724139}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.6935828}, {'id': 'https://openalex.org/C2780739214', 'wikidata': 'https://www.wikidata.org/wiki/Q6723023', 'display_name': 'Mace', 'level': 4, 'score': 0.64241886}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6244237}, {'id': 'https://openalex.org/C207103383', 'wikidata': 'https://www.wikidata.org/wiki/Q3930246', 'display_name': 'Hazard ratio', 'level': 3, 'score': 0.5929341}, {'id': 'https://openalex.org/C2910068830', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 Diabetes Mellitus', 'level': 3, 'score': 0.5636897}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.53303546}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.5282309}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.47953796}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.4673854}, {'id': 'https://openalex.org/C2780645631', 'wikidata': 'https://www.wikidata.org/wiki/Q671554', 'display_name': 'Stroke (engine)', 'level': 2, 'score': 0.42748144}, {'id': 'https://openalex.org/C2780323712', 'wikidata': 'https://www.wikidata.org/wiki/Q19484', 'display_name': 'Metformin', 'level': 3, 'score': 0.426156}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.41928592}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.36983347}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.35515833}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.33745638}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.25258043}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.15568346}, {'id': 'https://openalex.org/C2780400711', 'wikidata': 'https://www.wikidata.org/wiki/Q2008344', 'display_name': 'Percutaneous coronary intervention', 'level': 3, 'score': 0.090366244}, {'id': 'https://openalex.org/C2779306644', 'wikidata': 'https://www.wikidata.org/wiki/Q2002370', 'display_name': 'Insulin', 'level': 2, 'score': 0.065223396}, {'id': 'https://openalex.org/C78519656', 'wikidata': 'https://www.wikidata.org/wiki/Q101333', 'display_name': 'Mechanical engineering', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C127413603', 'wikidata': 'https://www.wikidata.org/wiki/Q11023', 'display_name': 'Engineering', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D003925', 'descriptor_name': 'Diabetic Angiopathies', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D058065', 'descriptor_name': 'Diabetic Cardiomyopathies', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D014498', 'descriptor_name': 'Uracil', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003925', 'descriptor_name': 'Diabetic Angiopathies', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D003925', 'descriptor_name': 'Diabetic Angiopathies', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D003925', 'descriptor_name': 'Diabetic Angiopathies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058065', 'descriptor_name': 'Diabetic Cardiomyopathies', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D058065', 'descriptor_name': 'Diabetic Cardiomyopathies', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D058065', 'descriptor_name': 'Diabetic Cardiomyopathies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015994', 'descriptor_name': 'Incidence', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016016', 'descriptor_name': 'Proportional Hazards Models', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012720', 'descriptor_name': 'Severity of Illness Index', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014498', 'descriptor_name': 'Uracil', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014498', 'descriptor_name': 'Uracil', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D014498', 'descriptor_name': 'Uracil', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/dom.12093', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S148394532', 'display_name': 'Diabetes Obesity and Metabolism', 'issn_l': '1462-8902', 'issn': ['1462-8902', '1463-1326'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23489301', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.87, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 24, 'referenced_works': ['https://openalex.org/W1526927233', 'https://openalex.org/W1580788756', 'https://openalex.org/W1967392270', 'https://openalex.org/W1968328731', 'https://openalex.org/W1977952802', 'https://openalex.org/W1994683547', 'https://openalex.org/W2001576661', 'https://openalex.org/W2027788348', 'https://openalex.org/W2034728834', 'https://openalex.org/W2037429235', 'https://openalex.org/W2059245135', 'https://openalex.org/W2061865937', 'https://openalex.org/W2071090755', 'https://openalex.org/W2085341566', 'https://openalex.org/W2086842286', 'https://openalex.org/W2104288577', 'https://openalex.org/W2106154942', 'https://openalex.org/W2125468958', 'https://openalex.org/W2126919962', 'https://openalex.org/W2128243640', 'https://openalex.org/W2140986962', 'https://openalex.org/W2141946042', 'https://openalex.org/W2161075296', 'https://openalex.org/W3147894994'], 'related_works': ['https://openalex.org/W4323661936', 'https://openalex.org/W4297967970', 'https://openalex.org/W3025911312', 'https://openalex.org/W2751043776', 'https://openalex.org/W2352435413', 'https://openalex.org/W2319845212', 'https://openalex.org/W2166623757', 'https://openalex.org/W2126122658', 'https://openalex.org/W2097546094', 'https://openalex.org/W1977109189'], 'abstract_inverted_index': {'Aim': [0], 'As': [1], 'there': [2], 'have': [3, 180], 'been': [4], 'concerns': [5], 'that': [6], 'some': [7], 'classes': [8], 'or': [9, 47], 'agents': [10, 111], 'for': [11, 56, 91, 101, 116], 'the': [12, 24, 28, 36, 52, 59, 136, 200, 208], 'treatment': [13, 130], 'of': [14, 27, 38, 67, 135, 161, 185, 212], 'type': [15, 194, 217], '2': [16, 195, 218], 'diabetes': [17, 219], 'may': [18], 'increase': [19], 'CV': [20, 39, 68, 119, 163, 187, 209], 'risk,': [21], 'we': [22], 'evaluated': [23, 35], 'cardiovascular': [25, 63], 'profile': [26, 211], 'dipeptidyl': [29], 'peptidase‐4': [30], 'inhibitor': [31], 'alogliptin.': [32], 'Methods': [33], 'We': [34], 'incidence': [37, 133], 'events': [40, 120, 164], 'in': [41, 51, 191, 214], 'patients': [42, 82, 97, 106, 144, 170, 192, 215], 'treated': [43, 98, 107, 145, 171], 'with': [44, 99, 108, 146, 172, 189, 193, 216], 'alogliptin,': [45], 'placebo': [46, 100], 'comparator': [48, 149, 175], 'antihyperglycaemic': [49], 'drugs': [50], 'clinical': [53], 'trial': [54, 204], 'database': [55], 'alogliptin': [57, 85, 147, 173, 190], 'using': [58], 'composite': [60], 'major': [61], 'adverse': [62], 'event': [64], '(MACE)': [65], 'endpoints': [66], 'death,': [69], 'non‐fatal': [70, 74], 'myocardial': [71], 'infarction': [72], 'and': [73, 87, 104, 114, 148, 174], 'stroke.': [75], 'Results': [76], 'The': [77, 132], 'pooled': [78], 'analysis': [79], 'included': [80], '4168': [81], 'exposed': [83], 'to': [84, 95, 129], '12.5': [86], '25': [88], 'mg': [89], 'daily': [90], '2023': [92], 'patient‐years': [93, 103], 'compared': [94], '691': [96], '263': [102], '1169': [105], 'other': [109, 159], 'antidiabetic': [110], '(metformin,': [112], 'sulfonylureas': [113], 'thiazolidinediones)': [115], '703': [117], 'patient‐years.': [118], 'were': [121, 139, 165], 'adjudicated': [122], 'by': [123], 'an': [124], 'expert': [125], 'endpoint': [126], 'committee': [127], 'blinded': [128], 'allocation.': [131], 'rates': [134], 'combined': [137], 'MACE': [138], 'not': [140, 166, 181], 'significantly': [141, 167], 'different': [142, 168], 'between': [143, 169], 'therapies': [150], '(hazard': [151], 'ratio=0.635,': [152], '95%': [153], 'confidence': [154], 'interval,': [155], '0.0,': [156], '1.41).': [157], 'Additionally,': [158], 'types': [160], 'serious': [162], 'therapies.': [176], 'Conclusion': [177], 'These': [178], 'analyses': [179], 'shown': [182], 'a': [183], 'signal': [184], 'increased': [186], 'risk': [188], 'diabetes.': [196], 'Future': [197], 'results': [198], 'from': [199], 'adequately': [201], 'powered': [202], 'EXAMINE': [203], 'will': [205], 'definitively': [206], 'assess': [207], 'safety': [210], 'aloglipin': [213], 'mellitus.': [220]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2125653714', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 8}, {'year': 2018, 'cited_by_count': 12}, {'year': 2017, 'cited_by_count': 12}, {'year': 2016, 'cited_by_count': 17}, {'year': 2015, 'cited_by_count': 18}, {'year': 2014, 'cited_by_count': 31}, {'year': 2013, 'cited_by_count': 6}], 'updated_date': '2024-08-31T23:35:46.613676', 'created_date': '2016-06-24'}